CD19 and acute lymphoblastic leukemia: Jacoby et al. (26) also found the exons 1-3 junctional transcript deletion in the E2a:PBX cell line of mice that acquired CD19-negative ALL relapses via CD19 exon-specific primers, implying the absence of exon 2.